Gilead Sciences
GILD
#126
Rank
$136.80 B
Marketcap
$109.98
Share price
-1.15%
Change (1 day)
71.12%
Change (1 year)

P/S ratio for Gilead Sciences (GILD)

P/S ratio as of June 2025 (TTM): 4.76

According to Gilead Sciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.17. At the end of 2025 the company had a P/S ratio of 4.85.

P/S ratio history for Gilead Sciences from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20254.8518.78%
20244.089.57%
20233.72-5.68%
20223.9518.36%
20213.3312.73%
20202.96-19.28%
20193.661.12%
20183.621.1%
20173.5815.47%
20163.10-29.58%
20154.41-22.34%
20145.68-44.82%
201310.378.9%
20125.7556.83%
20113.670.28%
20103.66-34.16%
20095.55-36.37%
20088.73-13.63%
200710.12.11%
20069.89-16.96%
200511.90.5%
200411.9-17.21%
200314.3-0.5%
200214.4-46.96%
200127.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Amgen
AMGN
4.65-2.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
10.5 121.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
5.88 23.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
3.17-33.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
1.95-59.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.23-53.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
4.23-11.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
15.0 215.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3.21-32.58%๐Ÿ‡บ๐Ÿ‡ธ USA